WO2004015416A3 - Procedes pour identifier des substances a action anti-microbienne - Google Patents

Procedes pour identifier des substances a action anti-microbienne Download PDF

Info

Publication number
WO2004015416A3
WO2004015416A3 PCT/EP2003/008145 EP0308145W WO2004015416A3 WO 2004015416 A3 WO2004015416 A3 WO 2004015416A3 EP 0308145 W EP0308145 W EP 0308145W WO 2004015416 A3 WO2004015416 A3 WO 2004015416A3
Authority
WO
WIPO (PCT)
Prior art keywords
agents
identification
methods
microbial action
eukaryotic cells
Prior art date
Application number
PCT/EP2003/008145
Other languages
German (de)
English (en)
Other versions
WO2004015416A2 (fr
Inventor
Gerald Kleymann
Hans-Otto Werling
Original Assignee
Bayer Healthcare Ag
Gerald Kleymann
Hans-Otto Werling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag, Gerald Kleymann, Hans-Otto Werling filed Critical Bayer Healthcare Ag
Priority to AU2003255282A priority Critical patent/AU2003255282A1/en
Publication of WO2004015416A2 publication Critical patent/WO2004015416A2/fr
Publication of WO2004015416A3 publication Critical patent/WO2004015416A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un nouveau procédé et son application pour identifier de nouvelles substances à action anti-microbienne. L'invention se caractérise en ce que, dans une préparation d'essai, des substances potentiellement actives sont mises en incubation simultanément avec des cellules eucaryotes et des microbes non viraux, la viabilité des cellules eucaryotes est déterminée, puis une sélection s'effectue pour choisir les substances actives pour lesquelles le signal de la préparation d'essai correspondante est significativement supérieur à la valeur moyenne des témoins d'infection pour au moins une concentration de la substance active.
PCT/EP2003/008145 2002-08-06 2003-07-24 Procedes pour identifier des substances a action anti-microbienne WO2004015416A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003255282A AU2003255282A1 (en) 2002-08-06 2003-07-24 Methods for the identification of agents with anti-microbial action

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002135967 DE10235967B4 (de) 2002-08-06 2002-08-06 Methode zum Identifizieren von Substanzen mit antimikrobieller Wirkung
DE10235967.9 2002-08-06

Publications (2)

Publication Number Publication Date
WO2004015416A2 WO2004015416A2 (fr) 2004-02-19
WO2004015416A3 true WO2004015416A3 (fr) 2004-05-06

Family

ID=30775043

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/008145 WO2004015416A2 (fr) 2002-08-06 2003-07-24 Procedes pour identifier des substances a action anti-microbienne

Country Status (3)

Country Link
AU (1) AU2003255282A1 (fr)
DE (1) DE10235967B4 (fr)
WO (1) WO2004015416A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0822260D0 (en) * 2008-12-05 2009-01-14 Merten Christoph Assay
CA3018026A1 (fr) 2016-04-06 2017-10-12 Innovative Molecules Gmbh Derives d'aminothiazole utiles en tant qu'agents antiviraux
MA50609B1 (fr) 2017-10-05 2023-03-31 Innovative Molecules Gmbh Énantiomères de thiazoles substitués utilisés comme composés antiviraux

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US5369095A (en) * 1990-02-14 1994-11-29 Alcon Laboratories, Inc. Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
US5501959A (en) * 1989-01-17 1996-03-26 Alamar Biosciences Laboratory, Inc. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents
US6046021A (en) * 1995-04-12 2000-04-04 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device
WO2001000209A1 (fr) * 1999-06-29 2001-01-04 Smithkline Beecham Corporation Methodes d'utilisation de composes fluoroquinolone pour lutter contre des bacteries
WO2001081920A2 (fr) * 2000-04-20 2001-11-01 Biolog, Inc. Analyse comparative de phenotypes pour l'evaluation de composes actifs biologiquement tels que des produits antimicrobiens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999029318A1 (fr) * 1997-12-11 1999-06-17 Biochem Pharma Inc. Composes antiviraux
GB9908195D0 (en) * 1999-04-09 1999-06-02 Microbiological Res Authority Treatment of intracellular infection

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US5501959A (en) * 1989-01-17 1996-03-26 Alamar Biosciences Laboratory, Inc. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents
US5369095A (en) * 1990-02-14 1994-11-29 Alcon Laboratories, Inc. Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
US6046021A (en) * 1995-04-12 2000-04-04 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a multiwell testing device
WO2001000209A1 (fr) * 1999-06-29 2001-01-04 Smithkline Beecham Corporation Methodes d'utilisation de composes fluoroquinolone pour lutter contre des bacteries
WO2001081920A2 (fr) * 2000-04-20 2001-11-01 Biolog, Inc. Analyse comparative de phenotypes pour l'evaluation de composes actifs biologiquement tels que des produits antimicrobiens

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AUBEL DOMINIQUE ET AL: "Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics", JOURNAL OF ANTIBIOTICS (TOKYO), vol. 54, no. 1, January 2001 (2001-01-01), pages 44 - 55, XP001160773, ISSN: 0021-8820 *
FISCHER AB: "Gentamycin as a bacteriocidal antibiotic in tissue culture", MED. MICROBIOL. IMMUNOL. (BERL.), vol. 161, no. 1, 1975, pages 23 - 39, XP008027169 *
SIMALA-GRANT J L ET AL: "Antibiotic susceptibility of attached and free-floating Helicobacter pylori.", THE JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. ENGLAND MAY 2001, vol. 47, no. 5, May 2001 (2001-05-01), pages 555 - 563, XP002268772, ISSN: 0305-7453 *

Also Published As

Publication number Publication date
DE10235967B4 (de) 2005-09-08
AU2003255282A1 (en) 2004-02-25
WO2004015416A2 (fr) 2004-02-19
DE10235967A1 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
WO2004029219A3 (fr) Interference arn basee sur les cellules, et procedes et compositions s'y rapportant
WO2003008636A3 (fr) Procede universel et composition pour la lyse rapide de cellules permettant la liberation d'acides nucleiques et leur detection
WO2006015209A3 (fr) Differenciation de cellules souches
BR0307630A (pt) Ultra-expressão de genes de extremozima em pseudomÈnades e bácterias proximamente relacionadas
WO2004011611A3 (fr) Anticorps anti-taci et utilisations de ceux-ci
AU2003241311A1 (en) Simple catalytic dna biosensors for ions based on color changes
WO2002084250A3 (fr) Procedes de detection par spectrometrie de masse et quantification de proteines cibles specifiques dans des echantillons biologiques complexes
WO2005020785A3 (fr) Decouverte du micro-organisme provoquant la maladie auto-immune humaine appelee cirrhose biliaire primaire
ATE347277T1 (de) Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln
WO2003008622A3 (fr) Amplification exponentielle d'acides nucleiques au moyen d'endonucleases de coupure
AU2003273276A1 (en) Methods and compositions for the preservation of cells, tissues or organs in the vitreous state
EP2266396A3 (fr) Modulation de cellules souches au moyen de proteines a doigts de zinc
WO2005123913A3 (fr) Compositions d'enzymes thermostables modifiees de façon reversible, et methodes de production et d'utilisation desdites compositions
CA2408348A1 (fr) Systemes de diagnostic concernant des cellules mixtes
MXPA01011182A (es) Metodos, composiciones y conjuntos para indicador biologico de esterilizacion.
DE60210485D1 (de) Verfahren zur bestimmung des vorhandenseins von bakterien, die gegen zell-lysierende antibiotika resistent sind
WO2002065091A3 (fr) Proteines ou acides nucleiques pin1 utilises comme marqueur de croissance cellulaire anormale
WO2005072290A3 (fr) Methodes de traitement, de diminution ou de prevention d'etats auto-immuns
AU2001279913A1 (en) Method for cellular lysis of prokaryotes and eukaryotes or simultaneous cellularlysis or prokaryotes and eukaryotes
WO2004015416A3 (fr) Procedes pour identifier des substances a action anti-microbienne
WO2000040232A3 (fr) Nouvelles compositions et trousses de bretylium, et leur utilisation dans la prevention et le traitement des pathologies cardio-vasculaires
TR199700796T1 (xx) Saprofitik maya kullan�m� ile hasat sonras� mantar hastal�klar�n�n kontrol alt�na al�nmas�.
EP1506785A4 (fr) Composition pour traiter ou prevenir une hyperuricemie
WO2003006497A3 (fr) Photoprotéines mutees et leurs applications
AU2003288621A1 (en) Rna bioassay

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP